We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
AUM
$71.1M
AUM Growth
+$4.73M
Cap. Flow
+$4.57M
Cap. Flow %
6.43%
Top 10 Hldgs %
34.33%
Holding
121
New
39
Increased
28
Reduced
18
Closed
35

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$1.68M
2
MCK icon
McKesson
MCK
+$1.54M
3
PFE icon
Pfizer
PFE
+$1.38M
4
SYK icon
Stryker
SYK
+$1.34M
5
GILD icon
Gilead Sciences
GILD
+$1.16M

Sector Composition

Rank Sector Weight
1 Healthcare 49.97%
2 Technology 9.06%
3 Communication Services 7.08%
4 Industrials 6.17%
5 Financials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRKR icon
51
Bruker
BRKR
$7.76B
$489K 0.69%
23,952
+8,277
+53% +$167K
BLUE
52
DELISTED
bluebird bio
BLUE
$482K 0.68%
221
-65
-23% -$132K
SIOX
53
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$464K 0.65%
+2,846
New +$482K
ACHC icon
54
Acadia Healthcare
ACHC
$2.89B
$436K 0.61%
+5,563
New +$400K
KPTI icon
55
Karyopharm Therapeutics
KPTI
$44.4M
$430K 0.6%
1,055
-433
-29% -$187K
HDP
56
DELISTED
Hortonworks, Inc.
HDP
$352K 0.5%
13,919
+8,188
+143% +$197K
DAL icon
57
Delta Air Lines
DAL
$61.1B
$346K 0.49%
8,434
+642
+8% +$28.1K
ALLY icon
58
Ally Financial
ALLY
$13.5B
$341K 0.48%
+15,200
New +$335K
ADAP
59
DELISTED
Adaptimmune Therapeutics
ADAP
$333K 0.47%
+18,194
New +$312K
KITE
60
DELISTED
Kite Pharma, Inc.
KITE
$333K 0.47%
5,458
+2,175
+66% +$124K
CYH icon
61
Community Health Systems
CYH
$412M
$332K 0.47%
+6,374
New +$286K
NFLX icon
62
Netflix
NFLX
$307B
$315K 0.44%
33,530
-4,830
-13% -$40.4K
MOH icon
63
Molina Healthcare
MOH
$10B
$283K 0.4%
4,031
-3,403
-46% -$228K
HLF icon
64
Herbalife
HLF
$1.19B
$245K 0.34%
+8,886
New +$215K
HOUS
65
DELISTED
Anywhere Real Estate
HOUS
$233K 0.33%
+4,979
New +$232K
CHRS icon
66
Coherus Oncology
CHRS
$180M
$203K 0.29%
+7,031
New +$178K
BPMC
67
DELISTED
Blueprint Medicines
BPMC
$195K 0.27%
+7,350
New +$210K
PGND
68
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$165K 0.23%
+5,740
New +$156K
ATML
69
DELISTED
ATMEL CORP
ATML
$158K 0.22%
+16,050
New +$141K
PTCT icon
70
PTC Therapeutics
PTCT
$5.86B
$135K 0.19%
2,812
+1,532
+120% +$89.4K
FOMX
71
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$112K 0.16%
+10,893
New +$120K
ONCE
72
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$112K 0.16%
+1,859
New +$123K
HAPN
73
Happen Inc
HAPN
$2.32B
$100K 0.14%
+1,363
New +$122K
HUM icon
74
PUT
Humana
HUM
$43.1B
$72K 0.1%
+12,900
New +$2.39M
THC icon
75
CALL
Tenet Healthcare
THC
$21B
$64K 0.09%
+17,900
New +$914K

Similar funds

Partner Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Partner Investment Management held 121 positions worth $71.1M, up 7.1% from $66.4M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Partner Investment Management deployed $4.57M of net new capital in Q2 2015, opening 39 new positions and adding to 28 existing holdings. Its largest new stake was Aetna Inc: 14,390 shares worth $1.83M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 52% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bausch Health, an estimated $1.68M trimmed.

  • Partner Investment Management's largest Q2 2015 buy was Aetna Inc: 14,390 shares worth $1.83M.
  • Partner Investment Management added most to HCA Healthcare in Q2 2015, an estimated $1.56M increase.
  • Partner Investment Management's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $1.68M.
  • Partner Investment Management fully exited McKesson in Q2 2015, selling an estimated $1.54M.
  • Partner Investment Management's ten largest holdings make up 34% of its $71.1M portfolio in Q2 2015.
  • Partner Investment Management opened 39 new positions and closed 35 in Q2 2015.
  • Partner Investment Management's portfolio value rose 7.1% quarter-over-quarter to $71.1M.

Based on Partner Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.